Published in Hum Mol Genet on December 22, 2008
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55
Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics (2010) 1.46
Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biol Psychiatry (2015) 1.44
Sounds of silence: synonymous nucleotides as a key to biological regulation and complexity. Nucleic Acids Res (2013) 1.44
Evolution of alternative and constitutive regions of mammalian 5'UTRs. BMC Genomics (2009) 1.31
Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev (2009) 1.18
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci (2010) 1.16
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin Pharmacol Ther (2011) 1.15
Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus. Biol Psychiatry (2010) 1.14
Molecular insights into mu opioid pharmacology: From the clinic to the bench. Clin J Pain (2010) 1.10
Cortical opioid markers in schizophrenia and across postnatal development. Cereb Cortex (2011) 1.06
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain (2010) 1.05
The genetics of the opioid system and specific drug addictions. Hum Genet (2012) 1.04
μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology (2012) 1.03
Opioids and their receptors: Are we there yet? Neuropharmacology (2013) 1.01
Novel rank-based approaches for discovery and replication in genome-wide association studies. Genetics (2011) 0.99
Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol (2011) 0.97
Recent advances in the use of opioids for cancer pain. J Pain Res (2009) 0.95
Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1. Mol Pain (2011) 0.95
Haplotype block structure of the genomic region of the mu opioid receptor gene. J Hum Genet (2010) 0.95
Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity. Pain (2012) 0.94
Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence. Alcohol Clin Exp Res (2010) 0.91
Attenuation of activity in an endogenous analgesia circuit by ongoing pain in the rat. J Neurosci (2010) 0.89
Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. J Med Toxicol (2013) 0.88
Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS (2014) 0.87
ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry (2013) 0.87
Evolution at protein ends: major contribution of alternative transcription initiation and termination to the transcriptome and proteome diversity in mammals. Nucleic Acids Res (2014) 0.86
Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain (2009) 0.86
Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene. Pain (2014) 0.86
Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? J Pain Res (2013) 0.86
Genetic variability of pain perception and treatment--clinical pharmacological implications. Eur J Clin Pharmacol (2011) 0.84
No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Drug Alcohol Depend (2011) 0.84
Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Clin Oncol (2012) 0.83
Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatol Int (2014) 0.83
Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res (2014) 0.81
Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol (2014) 0.81
Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation. PLoS One (2015) 0.81
Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids. Eur J Pain Suppl (2011) 0.80
Analgesia and central side-effects: two separate dimensions of morphine response. Br J Clin Pharmacol (2013) 0.80
Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics (2013) 0.80
Cocaine-induced suppression of saccharin intake and morphine modulation of Ca²⁺ channel currents in sensory neurons of OPRM1 A118G mice. Physiol Behav (2014) 0.79
Gender, variation in opioid receptor genes and sensitivity to experimental pain. Mol Pain (2013) 0.79
μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.79
Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis. J Cell Physiol (2015) 0.78
Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia. PLoS One (2015) 0.78
Polymorphisms in genes of respiratory control and sudden infant death syndrome. Int J Legal Med (2015) 0.77
The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene. PLoS One (2013) 0.77
Human population genetic structure detected by pain-related mu opioid receptor gene polymorphisms. Genet Mol Biol (2015) 0.77
Prenatal exposure to cigarette smoke interacts with OPRM1 to modulate dietary preference for fat. J Psychiatry Neurosci (2015) 0.76
Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR). Methods Mol Biol (2010) 0.76
Parent and peer influences on emerging adult substance use disorder: A genetically informed study. Dev Psychopathol (2016) 0.75
Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord (2017) 0.75
The design and methods of genetic studies on acute and chronic postoperative pain in patients after total knee replacement. Pain Med (2014) 0.75
Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine. Clin Chim Acta (2016) 0.75
Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? Transl Psychiatry (2014) 0.75
A "tail" of opioid receptor variants. J Clin Invest (2017) 0.75
β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. J Neurovirol (2016) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci (1997) 45.07
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered (2002) 8.64
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (1996) 7.15
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol (2002) 5.17
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem (2005) 3.53
Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A (2004) 3.34
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A (1997) 3.26
Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain (1999) 2.87
Selective constraint in intergenic regions of human and mouse genomes. Trends Genet (2001) 2.87
Increase of functional diversity by alternative splicing. Trends Genet (2003) 2.59
Low conservation of alternative splicing patterns in the human and mouse genomes. Hum Mol Genet (2003) 2.30
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain (2005) 2.23
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem (2004) 2.07
A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res (1997) 2.05
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain (2005) 2.00
The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A (1999) 1.96
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci (1999) 1.94
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet (2006) 1.93
Clinical pharmacology of opioids for pain. Clin J Pain (2002) 1.85
Recognition of unknown conserved alternatively spliced exons. PLoS Comput Biol (2005) 1.77
The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand (2004) 1.77
An experimental pain method sensitive to morphine in man: the submaximum effort tourniquet technique. J Pharmacol Exp Ther (1966) 1.70
Nucleotide frequency variation across human genes. Genome Res (2003) 1.68
A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem (2000) 1.65
OWEN: aligning long collinear regions of genomes. Bioinformatics (2002) 1.60
Multiple opiate receptors: déjà vu all over again. Neuropharmacology (2004) 1.59
Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand (2006) 1.54
A psychophysical analysis of morphine analgesia. Pain (1985) 1.53
Multifactorial preoperative predictors for postcesarean section pain and analgesic requirement. Anesthesiology (2006) 1.50
Comparative analysis of orthologous eukaryotic mRNAs: potential hidden functional signals. Nucleic Acids Res (2004) 1.49
Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain (2005) 1.47
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci U S A (1999) 1.41
Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol (2005) 1.37
Individual variability in the response to different opioids: report of five cases. Pain (1992) 1.36
Classification of common conserved sequences in mammalian intergenic regions. Hum Mol Genet (2002) 1.31
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther (2003) 1.31
Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain (2000) 1.31
Associations among four modalities of experimental pain in women. J Pain (2005) 1.22
How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci (2005) 1.22
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol (2001) 1.17
Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med (2005) 1.14
Analysis of internal loops within the RNA secondary structure in almost quadratic time. Bioinformatics (2006) 1.13
Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology (2006) 1.12
Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J Neurochem (2004) 1.12
Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun (2003) 1.10
Pharmacology of systemic analgesics. Best Pract Res Clin Anaesthesiol (2002) 1.07
Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain (2006) 1.01
A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain (2006) 0.99
Patterns in interspecies similarity correlate with nucleotide composition in mammalian 3'UTRs. Nucleic Acids Res (2003) 0.96
Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration. Genetics (2004) 0.92
Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene (2006) 0.92
Adjuncts to opioid therapy. J Am Osteopath Assoc (2002) 0.92
Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects. Genet Epidemiol (2009) 0.91
Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing. J Mol Med (Berl) (2004) 0.89
Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model. J Clin Pharmacol (2008) 0.84
Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells. Biochem Biophys Res Commun (1998) 0.82
Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice. BMC Mol Biol (2006) 0.82
A possible genetic mechanism underlying individual and interstrain differences in opioid actions: focus on the mu opioid receptor gene. Ann N Y Acad Sci (2004) 0.80
Evidence for opioid variability, Part 1: A biological perspective. Semin Perioper Nurs (2001) 0.80
Evidence for opioid variability, Part 2: Psychosocial influences. Semin Perioper Nurs (2001) 0.79
The minimum effective analgetic blood concentration of pethidine in patients with intractable pain. Br J Clin Pharmacol (1982) 0.77
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med (2003) 4.56
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25
An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res (2005) 3.94
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Studying sex and gender differences in pain and analgesia: a consensus report. Pain (2007) 3.58
Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry (2006) 3.44
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38
Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13
Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet (2003) 2.94
Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry (2003) 2.82
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet (2004) 2.71
Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet (2002) 2.60
Perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis. Pain (2009) 2.55
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain (2009) 2.53
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry (2002) 2.51
Ethnic differences in responses to multiple experimental pain stimuli. Pain (2005) 2.50
Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry (2004) 2.49
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain (2007) 2.37
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Deficiency in endogenous modulation of prolonged heat pain in patients with Irritable Bowel Syndrome and Temporomandibular Disorder. Pain (2009) 2.30
The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A (2003) 2.29
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med (2012) 2.25
A periodic pattern of mRNA secondary structure created by the genetic code. Nucleic Acids Res (2006) 2.24
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain (2005) 2.23
The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med (2009) 2.20
Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain (2004) 2.17
Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain (2010) 2.16
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry (2004) 2.12
Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain (2002) 2.11
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry (2006) 2.09
Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood (2003) 2.05
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature (2010) 2.00
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage (2006) 1.99
Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol (2006) 1.98
Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J (2010) 1.98
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. Pain (2008) 1.98
Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry (2004) 1.98
Selection in favor of nucleotides G and C diversifies evolution rates and levels of polymorphism at mammalian synonymous sites. J Theor Biol (2005) 1.88
Effect of two- and three-locus linkage disequilibrium on the power to detect marker/phenotype associations. Genetics (2004) 1.85
Multiple tests for genetic effects in association studies. Methods Mol Biol (2002) 1.85
Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain (2003) 1.85
Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain (2007) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol (2009) 1.81
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79
Time to Onset of Sustained Postoperative Pain Relief (SuPPR): Evaluation of a New Systems-level Metric for Acute Pain Management. Clin J Pain (2016) 1.79
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry (2008) 1.79
Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size. Anesthesiology (2004) 1.78
Pain measurement and brain activity: will neuroimages replace pain ratings? J Pain (2013) 1.76
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74